company background image
KRKG

Krka d. d LJSE:KRKG Stock Report

Last Price

€93.00

Market Cap

€2.9b

7D

-2.1%

1Y

-19.5%

Updated

30 Nov, 2022

Data

Company Financials +
KRKG fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends5/6

KRKG Stock Overview

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Krka, d. d. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Krka d. d
Historical stock prices
Current Share Price€93.00
52 Week High€120.00
52 Week Low€80.00
Beta0.49
1 Month Change4.03%
3 Month Change-4.71%
1 Year Change-19.48%
3 Year Change29.89%
5 Year Change72.22%
Change since IPO1,072.54%

Recent News & Updates

Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 48% Undervaluation?

Oct 26
Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 48% Undervaluation?

Here's Why We Think Krka d. d (LJSE:KRKG) Might Deserve Your Attention Today

Aug 30
Here's Why We Think Krka d. d (LJSE:KRKG) Might Deserve Your Attention Today

Recent updates

Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 48% Undervaluation?

Oct 26
Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 48% Undervaluation?

Here's Why We Think Krka d. d (LJSE:KRKG) Might Deserve Your Attention Today

Aug 30
Here's Why We Think Krka d. d (LJSE:KRKG) Might Deserve Your Attention Today

Krka d. d (LJSE:KRKG) Is Paying Out A Larger Dividend Than Last Year

Jun 24
Krka d. d (LJSE:KRKG) Is Paying Out A Larger Dividend Than Last Year

Is Now The Time To Put Krka d. d (LJSE:KRKG) On Your Watchlist?

May 19
Is Now The Time To Put Krka d. d (LJSE:KRKG) On Your Watchlist?

Krka d. d's (LJSE:KRKG) Upcoming Dividend Will Be Larger Than Last Year's

Apr 28
Krka d. d's (LJSE:KRKG) Upcoming Dividend Will Be Larger Than Last Year's

If You Like EPS Growth Then Check Out Krka d. d (LJSE:KRKG) Before It's Too Late

Feb 14
If You Like EPS Growth Then Check Out Krka d. d (LJSE:KRKG) Before It's Too Late

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Nov 24
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Here's Why We Think Krka d. d (LJSE:KRKG) Is Well Worth Watching

Oct 30
Here's Why We Think Krka d. d (LJSE:KRKG) Is Well Worth Watching

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Aug 11
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Increases to Krka, d. d.'s (LJSE:KRKG) CEO Compensation Might Cool off for now

Jul 02
Increases to Krka, d. d.'s (LJSE:KRKG) CEO Compensation Might Cool off for now

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 43%?

Mar 30
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 43%?

Is It Worth Buying Krka, d. d. (LJSE:KRKG) For Its 4.4% Dividend Yield?

Mar 11
Is It Worth Buying Krka, d. d. (LJSE:KRKG) For Its 4.4% Dividend Yield?

Krka, d. d.'s (LJSE:KRKG) Stock Has Fared Decently: Is the Market Following Strong Financials?

Feb 22
Krka, d. d.'s (LJSE:KRKG) Stock Has Fared Decently: Is the Market Following Strong Financials?

What You Need To Know About Krka, d. d.'s (LJSE:KRKG) Investor Composition

Feb 03
What You Need To Know About Krka, d. d.'s (LJSE:KRKG) Investor Composition

Shareholders Of Krka d. d (LJSE:KRKG) Must Be Happy With Their 93% Return

Jan 14
Shareholders Of Krka d. d (LJSE:KRKG) Must Be Happy With Their 93% Return

Calculating The Fair Value Of Krka, d. d. (LJSE:KRKG)

Dec 27
Calculating The Fair Value Of Krka, d. d. (LJSE:KRKG)

Does Krka, d. d. (LJSE:KRKG) Have A Place In Your Dividend Portfolio?

Dec 09
Does Krka, d. d. (LJSE:KRKG) Have A Place In Your Dividend Portfolio?

Could The Market Be Wrong About Krka, d. d. (LJSE:KRKG) Given Its Attractive Financial Prospects?

Nov 20
Could The Market Be Wrong About Krka, d. d. (LJSE:KRKG) Given Its Attractive Financial Prospects?

Shareholder Returns

KRKGSI PharmaceuticalsSI Market
7D-2.1%1.4%-0.7%
1Y-19.5%2.6%-14.4%

Return vs Industry: KRKG underperformed the SI Pharmaceuticals industry which returned 3% over the past year.

Return vs Market: KRKG underperformed the SI Market which returned -14.4% over the past year.

Price Volatility

Is KRKG's price volatile compared to industry and market?
KRKG volatility
KRKG Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement3.5%
10% most volatile stocks in SI Market4.5%
10% least volatile stocks in SI Market2.5%

Stable Share Price: KRKG is less volatile than 75% of SI stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: KRKG's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195411,489Jože Colarichttps://www.krka.biz

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others.

Krka, d. d. Fundamentals Summary

How do Krka d. d's earnings and revenue compare to its market cap?
KRKG fundamental statistics
Market Cap€2.89b
Earnings (TTM)€369.41m
Revenue (TTM)€1.63b

7.8x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
KRKG income statement (TTM)
Revenue€1.63b
Cost of Revenue€723.82m
Gross Profit€907.64m
Other Expenses€538.23m
Earnings€369.41m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)11.90
Gross Margin55.63%
Net Profit Margin22.64%
Debt/Equity Ratio0%

How did KRKG perform over the long term?

See historical performance and comparison

Dividends

6.1%

Current Dividend Yield

47%

Payout Ratio